We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
(+25%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$57.2M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$52.3M |
| 3 |
Micron Technology
MU
|
+$46M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
| 5 |
Apple
AAPL
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$76.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$62.9M |
| 3 |
NVR
NVR
|
+$49.7M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$37.5M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$35.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
First Commonwealth Financial
FCF
$2.12B
| $946K | 0.01% |
65,164
-13,446
| -17% | -$189K |
|
|
ALTA
702
DELISTED
Altabancorp
ALTA
| $942K | 0.01% |
31,279
+16,888
| +117% | +$495K |
|
|
LGF.A
703
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $937K | 0.01% |
+87,880
| New | +$809K |
|
704
BeyondSpring
BYSI
$46.1M
| $914K | 0.01% |
+58,986
| New | +$876K |
|
|
AVEO
705
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $908K | 0.01% |
+145,425
| New | +$1.07M |
|
706
Walmart Inc
WMT
$871B
| $901K | 0.01% |
22,737
-22,653
| -50% | -$900K |
|
707
Syndax Pharmaceuticals
SNDX
$1.84B
| $895K | 0.01% |
101,952
+22,208
| +28% | +$163K |
|
708
Titan International
TWI
$516M
| $885K | 0.01% |
244,361
-37,755
| -13% | -$112K |
|
|
PRSU
709
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $877K | 0.01% |
12,987
-21,490
| -62% | -$1.39M |
|
710
NCR Voyix
VYX
$1.06B
| $870K | 0.01% |
+40,328
| New | +$785K |
|
|
CALA
711
DELISTED
Calithera Biosciences, Inc
CALA
| $869K | 0.01% |
7,612
+5,321
| +232% | +$400K |
|
712
Myers Industries
MYE
$1.18B
| $866K | 0.01% |
51,917
+9,207
| +22% | +$153K |
|
713
Koppers
KOP
$966M
| $859K | 0.01% |
22,476
-66,610
| -75% | -$2.34M |
|
714
Qualys
QLYS
$4.84B
| $856K | 0.01% |
10,264
-1,796
| -15% | -$149K |
|
|
ELVT
715
DELISTED
Elevate Credit, Inc.
ELVT
| $846K | 0.01% |
190,157
+29,933
| +19% | +$125K |
|
|
EEX
716
DELISTED
Emerald Holding
EEX
| $843K | 0.01% |
79,917
+9,227
| +13% | +$91.7K |
|
|
CPRX
717
DELISTED
Catalyst Pharmaceutical
CPRX
| $842K | 0.01% |
224,665
+6,965
| +3% | +$32.6K |
|
718
PNC Financial Services
PNC
$100B
| $832K | 0.01% |
5,209
-1,961
| -27% | -$294K |
|
719
Eagle Materials
EXP
$6.6B
| $824K | 0.01% |
+9,092
| New | +$833K |
|
|
HOLX
720
DELISTED
Hologic
HOLX
| $816K | 0.01% |
15,630
+4,770
| +44% | +$237K |
|
|
UFS
721
DELISTED
DOMTAR CORPORATION (New)
UFS
| $816K | 0.01% |
+21,330
| New | +$790K |
|
|
BHR
722
Braemar Hotels & Resorts
BHR
$153M
| $806K | 0.01% |
90,312
+56,075
| +164% | +$524K |
|
723
Inseego
INSG
$108M
| $802K | 0.01% |
10,940
| – | – |
|
724
Noodles & Co
NDLS
$90.5M
| $797K | 0.01% |
+17,975
| New | +$794K |
|
725
Arcus Biosciences
RCUS
$3.57B
| $795K | 0.01% |
78,703
+33,556
| +74% | +$282K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2019 Portfolio in Review
As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.
- Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
- Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
- Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
- Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
- Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
- Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.